| Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis C Borga, G Park, C Foster, J Burroughs-Garcia, M Marchesin, R Shah, ... Leukemia 33 (2), 333-347, 2019 | 40 | 2019 |
| Myeloma cells deplete bone marrow glutamine and inhibit osteoblast differentiation limiting asparagine availability M Chiu, D Toscani, V Marchica, G Taurino, F Costa, MG Bianchi, ... Cancers 12 (11), 3267, 2020 | 32 | 2020 |
| Role of 1q21 in multiple myeloma: from pathogenesis to possible therapeutic targets J Burroughs Garcìa, RA Eufemiese, P Storti, G Sammarelli, L Craviotto, ... Cells 10 (6), 1360, 2021 | 30 | 2021 |
| PD-L1/PD-1 pattern of expression within the bone marrow immune microenvironment in smoldering myeloma and active multiple myeloma patients F Costa, R Vescovini, V Marchica, P Storti, L Notarfranchi, B Dalla Palma, ... Frontiers in immunology 11, 613007, 2021 | 20 | 2021 |
| Evolutionarily conserved function of Gbx2 in anterior hindbrain development J Burroughs‐Garcia, V Sittaramane, A Chandrasekhar, ST Waters Developmental Dynamics 240 (4), 828-838, 2011 | 19 | 2011 |
| Characterization of the Gbx1−/− mouse mutant: A requirement for Gbx1 in normal locomotion and sensorimotor circuit development DM Buckley, J Burroughs-Garcia, M Lewandoski, ST Waters PLoS One 8 (2), e56214, 2013 | 18 | 2013 |
| Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response P Storti, V Marchica, R Vescovini, V Franceschi, L Russo, L Notarfranchi, ... Oncoimmunology 11 (1), 2120275, 2022 | 12 | 2022 |
| Disparate Regulatory Mechanisms Control Fat3 and P75NTR Protein Transport through a Conserved Kif5-Interaction Domain H Cheng, J Burroughs-Garcia, JE Birkness, JC Trinidad, MR Deans PLoS One 11 (10), e0165519, 2016 | 10 | 2016 |
| Isolating malignant and non-malignant b cells from lck: eGFP zebrafish J Burroughs-Garcia, A Hasan, G Park, C Borga, JK Frazer JoVE (Journal of Visualized Experiments), e59191, 2019 | 9 | 2019 |
| Gbx1 and Gbx2 Are Essential for Normal Patterning and Development of Interneurons and Motor Neurons in the Embryonic Spinal Cord DM Buckley, J Burroughs-Garcia, S Kriks, M Lewandoski, ST Waters Journal of Developmental Biology 8 (2), 9, 2020 | 8 | 2020 |
| Fat3 acts through independent cytoskeletal effectors to coordinate asymmetric cell behaviors during polarized circuit assembly EC Avilés, A Krol, SJ Henle, J Burroughs-Garcia, MR Deans, LV Goodrich Cell reports 38 (5), 2022 | 7 | 2022 |
| Novel approaches to improve myeloma cell killing by monoclonal antibodies P Storti, F Costa, V Marchica, J Burroughs-Garcia, B Dalla Palma, ... Journal of Clinical Medicine 9 (9), 2864, 2020 | 7 | 2020 |
| Zebrafish B cell acute lymphoblastic leukemia: new findings in an old model G Park, J Burroughs-Garcia, CA Foster, A Hasan, C Borga, JK Frazer Oncotarget 11 (15), 1292, 2020 | 7 | 2020 |
| Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link? L Notarfranchi, V Marchica, B Dalla Palma, L Pelagatti, ... Acta Haematologica 144 (3), 302-307, 2021 | 5 | 2021 |
| The metabolic features of osteoblasts: implications for multiple myeloma (MM) bone disease O Lungu, D Toscani, J Burroughs-Garcia, N Giuliani International Journal of Molecular Sciences 24 (5), 4893, 2023 | 4 | 2023 |
| Molecular features of the mesenchymal and osteoblastic cells in multiple myeloma NT Iannozzi, V Marchica, D Toscani, J Burroughs Garcìa, N Giuliani, ... International Journal of Molecular Sciences 23 (24), 15448, 2022 | 3 | 2022 |
| A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors V Raimondi, NT Iannozzi, J Burroughs-Garcìa, D Toscani, P Storti, ... Exploration of Targeted Anti-tumor Therapy 3 (4), 463, 2022 | 3 | 2022 |
| Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease V Raimondi, D Toscani, V Marchica, J Burroughs-Garcia, P Storti, ... Frontiers in Oncology 12, 1015402, 2022 | 1 | 2022 |
| CD38 expression by plasma cells in extramedullary multiple myeloma L Notarfranchi, F Accardi, C Mancini, E Martella, S Bonomini, R Segreto, ... Haematologica 109 (4), 1297, 2024 | | 2024 |
| The impact of CD56 expression in smoldering myeloma patients on early progression. L Notarfranchi, R Segreto, R Vescovini, AB Dalla Palma, V Marchica, ... Hematological Oncology 41 (3), 2023 | | 2023 |
